JP2020508333A5 - - Google Patents

Download PDF

Info

Publication number
JP2020508333A5
JP2020508333A5 JP2019546211A JP2019546211A JP2020508333A5 JP 2020508333 A5 JP2020508333 A5 JP 2020508333A5 JP 2019546211 A JP2019546211 A JP 2019546211A JP 2019546211 A JP2019546211 A JP 2019546211A JP 2020508333 A5 JP2020508333 A5 JP 2020508333A5
Authority
JP
Japan
Prior art keywords
aqueous solution
antibody
use according
antibody protein
during storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019546211A
Other languages
English (en)
Japanese (ja)
Other versions
JP7278952B2 (ja
JP2020508333A (ja
Filing date
Publication date
Priority claimed from GBGB1703063.6A external-priority patent/GB201703063D0/en
Application filed filed Critical
Publication of JP2020508333A publication Critical patent/JP2020508333A/ja
Publication of JP2020508333A5 publication Critical patent/JP2020508333A5/ja
Priority to JP2022208841A priority Critical patent/JP2023052088A/ja
Application granted granted Critical
Publication of JP7278952B2 publication Critical patent/JP7278952B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019546211A 2017-02-24 2018-02-23 安定化された抗体タンパク質溶液 Active JP7278952B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022208841A JP2023052088A (ja) 2017-02-24 2022-12-26 安定化された抗体タンパク質溶液

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1703063.6A GB201703063D0 (en) 2017-02-24 2017-02-24 Stabilized antibody protein solutions
GB1703063.6 2017-02-24
PCT/GB2018/050480 WO2018154319A1 (en) 2017-02-24 2018-02-23 Stabilized antibody protein solutions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022208841A Division JP2023052088A (ja) 2017-02-24 2022-12-26 安定化された抗体タンパク質溶液

Publications (3)

Publication Number Publication Date
JP2020508333A JP2020508333A (ja) 2020-03-19
JP2020508333A5 true JP2020508333A5 (cg-RX-API-DMAC10.html) 2021-04-08
JP7278952B2 JP7278952B2 (ja) 2023-05-22

Family

ID=58544083

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019546211A Active JP7278952B2 (ja) 2017-02-24 2018-02-23 安定化された抗体タンパク質溶液
JP2022208841A Pending JP2023052088A (ja) 2017-02-24 2022-12-26 安定化された抗体タンパク質溶液

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022208841A Pending JP2023052088A (ja) 2017-02-24 2022-12-26 安定化された抗体タンパク質溶液

Country Status (5)

Country Link
US (1) US20200023062A1 (cg-RX-API-DMAC10.html)
EP (2) EP4289443A3 (cg-RX-API-DMAC10.html)
JP (2) JP7278952B2 (cg-RX-API-DMAC10.html)
GB (1) GB201703063D0 (cg-RX-API-DMAC10.html)
WO (1) WO2018154319A1 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3284480T3 (fi) 2015-04-14 2025-09-11 Chugai Pharmaceutical Co Ltd IL-31-antagonistia vaikuttavana ainesosana sisältävä farmaseuttinen koostumus atooppisen ihottuman ehkäisemiseksi ja/tai hoitamiseksi
US11608357B2 (en) * 2018-08-28 2023-03-21 Arecor Limited Stabilized antibody protein solutions
EP3372241A1 (en) 2017-03-06 2018-09-12 Ares Trading S.A. Liquid pharmaceutical composition
EP3372242A1 (en) 2017-03-06 2018-09-12 Ares Trading S.A. Liquid pharmaceutical composition
PE20212185A1 (es) 2019-02-18 2021-11-11 Lilly Co Eli Formulacion de anticuerpos terapeuticos
GB201911461D0 (en) * 2019-08-09 2019-09-25 Arecor Ltd Novel composition
WO2021100794A1 (ja) * 2019-11-20 2021-05-27 中外製薬株式会社 抗体含有製剤
EP4097145B1 (en) * 2020-01-30 2026-01-28 Leukocare Ag Reduction of adsorption
FI129383B (en) 2020-06-15 2022-01-31 Faron Pharmaceuticals Oy Stable anti-clever-1 antibody formulation
GB202102258D0 (en) * 2021-02-17 2021-03-31 Arecor Ltd Novel composition
CN121002123A (zh) 2023-03-28 2025-11-21 住友化学株式会社 树脂组合物、成型体及树脂组合物的制造方法
CN117007791B (zh) * 2023-07-18 2024-08-09 广州市进德生物科技有限公司 一种辣根过氧化物酶偶联物稀释保存液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2476934C (en) 2002-02-27 2009-06-16 Immunex Corporation Stabilized tnfr-fc composition comprising arginine
PA8661401A1 (es) 2005-01-28 2006-09-08 Wyeth Corp Formulaciones del liquido polipeptido estabilizado
CA2618068C (en) 2005-08-05 2016-02-16 Amgen Inc. Stable aqueous protein or antibody pharmaceutical formulations and their preparation
TW200806317A (en) 2006-03-20 2008-02-01 Wyeth Corp Methods for reducing protein aggregation
GB0700523D0 (en) 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
PE20091174A1 (es) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
EP2598167B1 (en) * 2010-07-30 2015-04-01 Arecor Limited Stabilized aqueous antibody compositions
EP3372241A1 (en) * 2017-03-06 2018-09-12 Ares Trading S.A. Liquid pharmaceutical composition

Similar Documents

Publication Publication Date Title
JP2020508331A5 (cg-RX-API-DMAC10.html)
JP6791929B2 (ja) タンパク質含有製剤の安定化に有用な組成物及び方法
KR102289825B1 (ko) 이온성 액체를 함유하는 액체 단백질 제형
US20240239884A1 (en) SOLUTION FORMULATIONS OF ENGINEERED ANTI-IL-23p19 ANTIBODIES
CA2971800C (en) Secukinumab compositions, uses and kits thereof, and processes for stabilizing antibody formulations
JP7278952B2 (ja) 安定化された抗体タンパク質溶液
CN102458469B (zh) 人抗TNF-α抗体的稳定高蛋白质浓度制剂
US9556280B2 (en) Anti-TFPI antibody variants with differential binding across PH range for improved pharmacokinetics
TW201632203A (zh) 用於單株抗體的穩定液體製劑
TW201343177A (zh) 含抗Ａｎｇ－２抗體之安定化調配物
JP7589168B2 (ja) タンパク質含有製剤を安定化するための組成物および方法
JP2023071755A (ja) 安定化された抗体溶液
MX2012014862A (es) Composiciones y metodos para estabilizar formulaciones que contienen proteinas.
KR20150024301A (ko) 생물학적 치료제 및 구아니딘 또는 구아니딘 유도체를 함유하는 수성 약제학적 조성물 및 당해 조성물을 포함하는 주사제
JP2024528724A (ja) 抗ｐｄ－１抗体医薬組成物及びその使用
CN114206391B (zh) 包含抗体的新组合物
CA3208945A1 (en) Aqueous composition of an engineered protein construct comprising an fc domain
KR20240099311A (ko) 제제
HK1184379B (en) Compositions and methods containing alkylgycosides for stabilizing protein- containing formulations